What is BRKR's five-year median EV/EBITDA?

21.1x. Half of BRKR's weekly readings over the last five years were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares BRKR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Bruker Corp (BRKR) valuation history

Health Care

$57.59

Latest weekly close · Market cap $8.8B

Historically high

As of Oct 24, 2026

BRKR's EV/EBITDA of 52.1x is higher than 97% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 21.1×

5-year median: 21.1×
10-year median: 20.3×
5-year low to high: 15.8×–57.2×
Versus 5-year median: +147%

EV/EBITDA

97thpercentile

of its weekly readings over the last five years

Historically high

Growth, last 12 months vs the year before

Revenue: +2%slowing
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

BRKR EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	32.2×	98
Dec 30, 2024	24.7×	75
Dec 25, 2023	20.4×	47
Dec 26, 2022	20.7×	58
Dec 27, 2021	26.3×	86
Dec 28, 2020	25.9×	99
Dec 30, 2019	22.2×	91
Dec 31, 2018	14.5×	1
Dec 25, 2017	21.2×	89
Dec 26, 2016	14.8×	27

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare BRKR with peers

Health Care peers of BRKR on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AAgilent Technologies	26.9×	Historically high	91
AVTRAvantor Inc	128.7×	Historically high	100
BIOBio-Rad Laboratories Inc	n/a	Not ranked	n/a, not ranked
CRLCharles River Laboratories	48.3×	Historically high	100
DHRDanaher Corporation	24.5×	Within its usual range	61

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on BRKR

No articles about BRKR yet. How valuation percentiles work

Loading peers and related research…

About this history

What is BRKR's current EV/EBITDA?: BRKR's EV/EBITDA of 52.1x is higher than 97% of its weekly readings over the last five years.
What is BRKR's five-year median EV/EBITDA?: 21.1x. Half of BRKR's weekly readings over the last five years were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares BRKR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.